Oxford’s COVID-19 vaccine has better immune response with two-dose regime
London: Oxford’s COVID-19 vaccine candidate has a better immune response when a two full-dose regime is used rather than a ...
Read moreLondon: Oxford’s COVID-19 vaccine candidate has a better immune response when a two full-dose regime is used rather than a ...
Read moreNew Delhi: British Prime Minister Boris Johnson will visit India next month to attend the Republic Day celebrations as the ...
Read moreNew Delhi: Results of an interim analysis of the Phase III programme conducted by Oxford University with AZD1222, peer-reviewed and ...
Read moreNew Delhi: After Pfizer and Serum Institute, Hyderabad-based pharmaceutical firm Bharat Biotech applied Monday to the central drug regulator seeking ...
Read moreNew Delhi: Serum Institute of India (SII), the world’s largest vaccine manufacturer, denied allegations Tuesday that a COVID-19 trial volunteer ...
Read moreLondon: AstraZeneca and Oxford University have acknowledged a manufacturing error that is raising questions about preliminary results of their experimental ...
Read moreLondon: Indian para-athlete and current World Champion Manasi Joshi and climate activist Ridhima Pandey are among four Indian women to ...
Read moreLondon: Pharmaceutical giants AstraZeneca said Monday its vaccine for the novel coronavirus could be around 90 per cent effective without ...
Read moreFrankfurt: Pharma giants Moderna will charge governments between $25 (Rs 1,800 approximately) and $37 (Rs 2,500) per dose of its ...
Read moreLondon: The coronavirus vaccine developed by teams at the University of Oxford has shown some promising results also. The coronavirus ...
Read more